The Merck Manual Is Introduced in its 20th Edition
Kenilworth, N.J., May 22, 2018 – Trusted by doctors and other healthcare professionals for more...
Lipid
New CDC report: How many Americans have diabetes or prediabetes?
Diabetes was the seventh leading cause of death in the U.S. in 2015. More than 100 million U.S....
Lipid Control: The Impact of Financial Incentives
Despite the well-documented benefits of statins to lower LDL cholesterol (LDL-C) and help reduce...
Updated Stroke Prevention Guidelines
The American Heart Association and American Stroke Association (AHA/ASA) have updated guidelines...
Cholesterol & Cardiorespiratory Fitness
Published research suggests that cholesterol levels commonly rise as people age and then decrease...
Aspirin Use for Primary CVD Prevention
With cardiovascular disease (CVD) continuing to be the leading cause of death in the United...
Taking a Patient-Centered Approach to Managing Cholesterol
The National Lipid Association (NLA) has released new recommendations to guide healthcare...
Conference Highlights: AHA 2015
New research was presented at AHA 2015, the American Heart Association’s annual Scientific...
Activities of Daily Living with Heart Failure
Physical disability and loss of independence can complicate the care of patients with heart...
Cardiometabolic Multi-Morbidity & Mortality
Mortality rates per 1,000 person-years appear to be similar among patients with diabetes (15.6), stroke (16.1), or myocardial infarction (16.8), according to a large study. The mortality rate per 1,000 person-years was 32.0 for...
Analyzing 10-Year ASCVD Risk Thresholds
Study results suggest that the current 10-year atherosclerotic cardiovascular disease (ASCVD) risk threshold (7.5%) used in the American College of Cardiology/American Heart Association cholesterol treatment guidelines appears...
IL-10: A New Target for Lipid Abnormalities
Increased interleukin-10 (IL-10) appears to cause severe HDL cholesterol deficiency and raises triglyceride levels, according to a study. Results of the study suggest that IL-10 is a potent modulator of lipoprotein levels and...
